English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 68 | Tables: 117 | Pharma & Healthcare
Human Chorionic Gonadotrophin (HCG) is a hormone produced during pregnancy. It is used as an indicator in pregnancy tests and can also be administered medically for various purposes.
The global Human Chorionic Gonadotrophin (HCG) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Chorionic Gonadotrophin (HCG) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Chorionic Gonadotrophin (HCG) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Chorionic Gonadotrophin (HCG) in Drug is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Chorionic Gonadotrophin (HCG) include Qingdao Kangyuan Pharmaceutical Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Jiangxi Haoran Biopharmaceutical Co., Ltd. and Shanghai Tianwei Biopharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotrophin (HCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotrophin (HCG).
Report Scope
The Human Chorionic Gonadotrophin (HCG) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Chorionic Gonadotrophin (HCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Chorionic Gonadotrophin (HCG) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.
Segment by Type
u-hCG
r-hCG
Segment by Application
Drug
Pregnancy Test Paper
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Chorionic Gonadotrophin (HCG) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 u-hCG
1.2.3 r-hCG
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotrophin (HCG) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug
1.3.3 Pregnancy Test Paper
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Chorionic Gonadotrophin (HCG) Market Perspective (2019-2030)
2.2 Human Chorionic Gonadotrophin (HCG) Growth Trends by Region
2.2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Chorionic Gonadotrophin (HCG) Historic Market Size by Region (2019-2024)
2.2.3 Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Region (2025-2030)
2.3 Human Chorionic Gonadotrophin (HCG) Market Dynamics
2.3.1 Human Chorionic Gonadotrophin (HCG) Industry Trends
2.3.2 Human Chorionic Gonadotrophin (HCG) Market Drivers
2.3.3 Human Chorionic Gonadotrophin (HCG) Market Challenges
2.3.4 Human Chorionic Gonadotrophin (HCG) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Chorionic Gonadotrophin (HCG) Players by Revenue
3.1.1 Global Top Human Chorionic Gonadotrophin (HCG) Players by Revenue (2019-2024)
3.1.2 Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Players (2019-2024)
3.2 Global Human Chorionic Gonadotrophin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Chorionic Gonadotrophin (HCG) Revenue
3.4 Global Human Chorionic Gonadotrophin (HCG) Market Concentration Ratio
3.4.1 Global Human Chorionic Gonadotrophin (HCG) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotrophin (HCG) Revenue in 2023
3.5 Human Chorionic Gonadotrophin (HCG) Key Players Head office and Area Served
3.6 Key Players Human Chorionic Gonadotrophin (HCG) Product Solution and Service
3.7 Date of Enter into Human Chorionic Gonadotrophin (HCG) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Chorionic Gonadotrophin (HCG) Breakdown Data by Type
4.1 Global Human Chorionic Gonadotrophin (HCG) Historic Market Size by Type (2019-2024)
4.2 Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Type (2025-2030)
5 Human Chorionic Gonadotrophin (HCG) Breakdown Data by Application
5.1 Global Human Chorionic Gonadotrophin (HCG) Historic Market Size by Application (2019-2024)
5.2 Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Chorionic Gonadotrophin (HCG) Market Size (2019-2030)
6.2 North America Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024)
6.4 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotrophin (HCG) Market Size (2019-2030)
7.2 Europe Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024)
7.4 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size (2019-2030)
8.2 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Chorionic Gonadotrophin (HCG) Market Size (2019-2030)
9.2 Latin America Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024)
9.4 Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size (2019-2030)
10.2 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qingdao Kangyuan Pharmaceutical Co., Ltd.
11.1.1 Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Detail
11.1.2 Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
11.1.3 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.1.4 Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
11.1.5 Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Development
11.2 Ningbo Renjian Pharmaceutical Group Co., Ltd.
11.2.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Detail
11.2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
11.2.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
11.2.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Development
11.3 Jiangxi Haoran Biopharmaceutical Co., Ltd.
11.3.1 Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Detail
11.3.2 Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
11.3.3 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.3.4 Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
11.3.5 Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Development
11.4 Shanghai Tianwei Biopharmaceutical Co., Ltd.
11.4.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Detail
11.4.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
11.4.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.4.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
11.4.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of u-hCG
Table 3. Key Players of r-hCG
Table 4. Global Human Chorionic Gonadotrophin (HCG) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Chorionic Gonadotrophin (HCG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Chorionic Gonadotrophin (HCG) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region (2019-2024)
Table 8. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region (2025-2030)
Table 10. Human Chorionic Gonadotrophin (HCG) Market Trends
Table 11. Human Chorionic Gonadotrophin (HCG) Market Drivers
Table 12. Human Chorionic Gonadotrophin (HCG) Market Challenges
Table 13. Human Chorionic Gonadotrophin (HCG) Market Restraints
Table 14. Global Human Chorionic Gonadotrophin (HCG) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Chorionic Gonadotrophin (HCG) Market Share by Players (2019-2024)
Table 16. Global Top Human Chorionic Gonadotrophin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotrophin (HCG) as of 2023)
Table 17. Ranking of Global Top Human Chorionic Gonadotrophin (HCG) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Chorionic Gonadotrophin (HCG) Product Solution and Service
Table 21. Date of Enter into Human Chorionic Gonadotrophin (HCG) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Chorionic Gonadotrophin (HCG) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Type (2019-2024)
Table 25. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Type (2025-2030)
Table 27. Global Human Chorionic Gonadotrophin (HCG) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Application (2019-2024)
Table 29. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Application (2025-2030)
Table 31. North America Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Detail
Table 47. Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
Table 48. Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 49. Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024) & (US$ Million)
Table 50. Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Development
Table 51. Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Detail
Table 52. Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
Table 53. Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 54. Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024) & (US$ Million)
Table 55. Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Development
Table 56. Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Detail
Table 57. Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
Table 58. Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 59. Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024) & (US$ Million)
Table 60. Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Development
Table 61. Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Detail
Table 62. Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
Table 63. Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 64. Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2019-2024) & (US$ Million)
Table 65. Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Chorionic Gonadotrophin (HCG) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Chorionic Gonadotrophin (HCG) Market Share by Type: 2023 VS 2030
Figure 3. u-hCG Features
Figure 4. r-hCG Features
Figure 5. Global Human Chorionic Gonadotrophin (HCG) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Chorionic Gonadotrophin (HCG) Market Share by Application: 2023 VS 2030
Figure 7. Drug Case Studies
Figure 8. Pregnancy Test Paper Case Studies
Figure 9. Other Case Studies
Figure 10. Human Chorionic Gonadotrophin (HCG) Report Years Considered
Figure 11. Global Human Chorionic Gonadotrophin (HCG) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Human Chorionic Gonadotrophin (HCG) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region: 2023 VS 2030
Figure 14. Global Human Chorionic Gonadotrophin (HCG) Market Share by Players in 2023
Figure 15. Global Top Human Chorionic Gonadotrophin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotrophin (HCG) as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue in 2023
Figure 17. North America Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Human Chorionic Gonadotrophin (HCG) Market Share by Country (2019-2030)
Figure 19. United States Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Human Chorionic Gonadotrophin (HCG) Market Share by Country (2019-2030)
Figure 23. Germany Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Share by Region (2019-2030)
Figure 31. China Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Human Chorionic Gonadotrophin (HCG) Market Share by Country (2019-2030)
Figure 39. Mexico Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Share by Country (2019-2030)
Figure 43. Turkey Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
Figure 46. Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
Figure 47. Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
Figure 48. Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
